This review summarizes recent evidence on how mid‐life hypertension,
hyperhomocysteinemia (HHcy) and blood pressure variability, as well as late‐life …

Cognitive dysfunction (CD) in heart failure (HF) adversely affects treatment compliance and
quality of life. Although ryanodine receptor type 2 (RyR2) has been linked to cardiac muscle …

Heart failure (HF) is a major global healthcare problem accounting for substantial
deterioration of prognosis. As a complex clinical syndrome, HF often coexists with multi …

Alzheimer's disease is a neurodegenerative disorder in which the pathological accumulation
of amyloid-β and tau begins years before symptom onset. Emerging evidence suggests that …

Over 55 million people globally are living with dementia and, by 2050, this number is
projected to increase to 131 million. This poses immeasurable challenges for patients and …

The aim of this study is to analyze the risk factors that lead to cognitive impairment,
depression, and psychosocial problems in type 2 diabetes and discern what aspects they …

Heart failure (HF) is a chronic condition affecting millions of people worldwide. While the
cardinal manifestations of HF are related to the cardiovascular system, it has become …

Alzheimer's disease is increasing in prevalence disproportionately to longevity, placing
enormous burden on individuals, families, healthcare systems and the economy …

Simple Summary Cognitive impairment (CI) and dementia are common in patients with heart
attacks, and both share common cardiovascular risk factors. In our ageing population, the …

Growing evidence suggests that atrial fibrillation (AF), in addition to its thromboembolic risk,
is a risk factor for cognitive impairment (CI) via several pathways and mechanisms, further …